News 
-
Developing new biomarkers for cancer diagnostics
02.02.2012
Read the press release in Finnish >>>
Read more » -
The Finnish Red Cross Blood Service and Baxter to partner in plasma processing
13.01.2012
Read more » -
Culminatum tukee bio- ja lääkeyritysten kansainvälistymistä palveluliiketoiminnan koulutuksella
13.01.2012
Kansainvälisillä markkinoilla toimiva lääketeollisuus ulkoistaa toimintojaan, joten tuotekehityspalveluille ja muille korkean osaamisen asiantuntijapalveluille on maailmalla kasvava tarve. Culminatum Innovation Oy:n koulutusohjelma auttaa bio- ja lääkealan yrityksiä hyödyntämään tätä mahdollisuutta.
Read more » -
Culminatum works to develop an attractive innovation environment for biotechnology in the BSR
03.01.2012
An article by Pekka Ihalmo in the Baltic Rim Economies quarterly review.
Read more » -
Women as innovators
16.12.2011
Read more » -
Sartorius closes acquisition of the Biohit liquid handling business
15.12.2011
Sartorius expands it's product offering for laboratory applications by the acquisition of the Biohit liquid handling business.
Read more » -
Hermo Pharma selected as one of the 30 most promising Finnish growth companies
09.12.2011
Read more » -
Plexpress launches Yeast TRAC service
05.12.2011
The patented TRAC technology is used for measuring the expression levels of multiple genes form yeast cell lysates.
Read more » -
Finnish diabetes technology company Mendor starts co-operation in the Baltic region with Mediq
01.12.2011
Diabetes technology growth company Mendor has made a distribution agreement in the Balticregion with the international health care company Mediq. The agreement encompassesdistribution of Mendor’s products in Estonia, Latvia and Lithuania.
Read more » -
Nexstim announces landmark study on clinical value of Navigated Brain Stimulation for pre-surgical cortical motor mapping published in the journal Neurosurgery
01.12.2011
A German study reported influences of Navigated Brain Stimulation on the surgical planning. Read the article >>>
Read more » -
Neurotar completes the second round of investment in November 2011
30.11.2011
Neurotar registers 1200 new shares on 28.12.2011.
Read more » -
Sample collection for the Finnish haematological registry and biobank has been launched
30.11.2011
Sample collection from patients suffering from haematological diseases has been started for the Haematological biobank in the Hospital district of Helsinki and Uusimaa.
Read more » -
Innovation award winners in the Baltic Sea Region
02.11.2011
The HealthPort Innovation Award was today distributed during the 10th ScanBalt Forum to four dedicated winners. The objective of the award is to boost the commercial utilization of the ideas arising from the clinical environment and the healthcare researchers in the Baltic Sea Region. The four ideas and the winners are:
Read more » -
HealthPort Innovation Award to be distributed at ScanBalt Forum 2011
01.09.2011
The competition boosts the commercial utilization of ideas arising from the clinical environment and healthcare research in the Baltic Sea Region in addition with the neighbouring region Northern Netherlands. Awards will be granted to ideas and inventions in the area of healthcare and medical technology (e.g. medical and therapeutic tools and technologies, diagnostics, laboratory and hospital equipment and technology) and related services.
Read more » -
Finnish neuroscientific expertise: a good investment target
19.08.2011
Now arising in Finland is a cluster of neuroscience companies that is both highly interesting, even from an international perspective, and whose operation is supported by high-level, versatile basic research. Prospects are good, as the global market in neurotechnology – a field of technology related to diseases of the central nervous system – is in the region of 100 billion euros and grows by 3–4 per cent annually.
Read more » -
Academy Projects in health research get EUR 16 million
23.06.2011
The Academy of Finland’s Research Council for Health has granted Academy Projects a total of some 16 million euros in funding. In the October 2010 call, the Research Council received 146 applications for Academy Project funding.
Read more » -
Mendor raises € 8.1 Million in a Series B financing round for global market expansion
21.06.2011
Mendor, a leading company in new diabetes technologies and services, announces € 8.1 Million of Venture Capital financing to facilitate its global market expansion. The series-B financing round was led by the Finnish entrepreneur and investor Risto Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and the Finnvera Venture Capital as a returning investor.
Read more » -
Several methods for early diagnosis of Alzheimer's disease developed by European scientists
15.06.2011
European scientists have taken several significant steps to enable earlier diagnosis of Alzheimer’s disease in PredictAD, an EU-funded project. The scientists have developed new approaches for measuring biomarkers for diagnostics and a novel system for integrating the information systematically. The Scientific Coordinator of the project is Dr Jyrki Lötjönen from VTT Technical Research Centre of Finland.
Read more » -
New Centre of Excellence resolving connections between immune system and inflammatory diseases
13.06.2011
The Finnish Academy chose Molecular Systems Immunology and Physiology Research Group as one of its new Centres of Excellence (CoE) for the period of 2012 – 2017. Solving the mechanisms how type 1 diabetes develops is one of the main focuses of the venture.
Read more » -
Mendor Selected as a Red Herring Top 100 Europe Tech Startup
30.05.2011
Red Herring announced its Top 100 award in recognition of the leading private companies from Europe, celebrating these startups’ innovations and technologies across their respective industries.
Read more »
